MiR-122 overexpression alleviates oxygen–glucose deprivation-induced neuronal injury by targeting sPLA2-IIA
Open Access
- 10 May 2024
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 15, 1395833
Abstract
Background: Ischemic stroke (IS) is a neurological disease with significant disability and mortality. MicroRNAs were proven to be associated with cerebral ischemia. Previous studies have demonstrated miR-122 downregulation in both animal models of IS and the blood of IS patients. Nonetheless, the role and mechanism of miR-122-5p in IS remain unclear.Methods: We established primary human and mouse astrocytes, along with HT22 mouse hippocampal neuronal cells, through oxygen–glucose deprivation/reoxygenation (OGD/R) treatment. To assess the impact of miR-122, we employed CCK8 assays, flow cytometry, RT-qPCR, western blotting, and ELISA to evaluate cell viability, apoptosis, reactive oxygen species (ROS) generation, and cytokine expression. A dual-luciferase reporter gene assay was employed to investigate the interaction between miR-122 and sPLA2-IIA.Results: Overexpression of miR-122 resulted in decreased apoptosis, reduced cleaved caspase-3 expression, and increased cell viability in astrocytes and HT22 cells subjected to OGD/R. RT-qPCR and ELISA analyses demonstrated a decrease in mRNA and cytokine levels of interleukin (IL)-6 and tumor necrosis factor (TNF)-α in both astrocytes and HT22 cells following miR-122 overexpression. Moreover, miR-122 overexpression reversed OGD/R-induced ROS levels and 8-OHdG formation in astrocytes. Additionally, miR-122 overexpression decreased the mRNA and protein expression of inducible nitric oxide synthase (iNOS). Furthermore, we found that miR-122 attaches to the 3′-UTR of sPLA2-IIA, thereby downregulate its expression.Conclusion: Our study demonstrates that miR-122-mediated inhibition of sPLA2-IIA attenuates OGD/R-induced neuronal injury by suppressing apoptosis, alleviating post-ischemic inflammation, and reducing ROS production. Thus, the miR-122/sPLA2-IIA axis may represent a promising target for IS treatment.Keywords
This publication has 42 references indexed in Scilit:
- Nucleic acid drug and delivery techniques for disease therapy: Present situation and future prospectInterdisciplinary Medicine, 2024
- Flavonoids and ischemic stroke-induced neuroinflammation: Focus on the glial cellsBiomedicine & Pharmacotherapy, 2023
- The Role of Astrocytic Mitochondria in the Pathogenesis of Brain IschemiaMolecular Neurobiology, 2023
- A new insight into the role of pericytes in ischemic strokeActa Neurologica Belgica, 2023
- Therapeutic strategies and promising vaccine for hepatitis C virus infectionImmunity, Inflammation and Disease, 2023
- Neuroinflammation in Acute Ischemic and Hemorrhagic StrokeCurrent Neurology and Neuroscience Reports, 2023
- MicroRNA: An Emerging Predictive, Diagnostic, Prognostic and Therapeutic Strategy in Ischaemic StrokeCellular and Molecular Neurobiology, 2020
- Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studiesExperimental Neurology, 2020
- Relation between lipoprotein-associated phospholipase A2 mass and incident ischemic stroke severityNeurological Sciences, 2018
- Beneficial potential of intravenously administered IL-6 in improving outcome after murine experimental strokeBrain, Behavior, and Immunity, 2017